Pfizer plans to work with the European medicines agency (EMA) to resubmit marketing authorization application (MAA)
While the CHMP considered that treatment with XELJANZ resulted in reduction in the signs and symptoms of RA and improvement ...
Thursday, October 8, 2026
ADVERTISEMENT
Tag: RA
FasterCapital: ZudoMart Reaches Local Traction and Product Feedback Milestones
ZudoMart , a Nigeria-based marketplace for entrepreneurs and content creators, is reporting a series of early commercial and product milestones...
Read moreDetails
PressCenter.com is state-of-the-art Press Release Distribution Platform. PressCenter.com send and track your Press Release using our industry-leading global Media Contacts Database of a million contacts. Your Press Release will reach business news editors and journalists, in targeted sectors and territories or worldwide.